Moreover, patients with chronic autoimmune diseases or chronic GvHD that were refractory to first-line treatment with steroids and to second-line treatment with TNF blockers, etanercept (TNF decoy receptor) or infliximab (chimeric recombinant anti-TNF antibody), sometimes suffered from worsened symptoms [87]. The gene discussed is TNF; the disease is chronic graft versus host disease.